References
- World Health Organisation. Global Alliance for Vaccines and Immunization. Fact Sheet N°169. 2011. Available from: http://www.who.int/mediacentre/factsheets/fs169/en/ [cited 10 July 2015]..
- Ehreth J . The economics of vaccination from a global perspective: Present and future. 2–3 December, 2004, Vaccines: All things considered, San Francisco, CA, USA. Expert Rev Vaccines. 2005; 4(1): 19–21.
- Wicker S , Maltezou HC . Vaccine-preventable diseases in Europe: Where do we stand?. Expert Rev Vaccines. 2014; 13(8): 979–87.
- Bloom DE , Canning D , Weston M . The value of vaccination. World Econ. 2005; 6(3): 15–35.
- Loeppke R , Nicholson S , Taitel M , Sweeney M , Haufle V , Kessler RC . The impact of an integrated population health enhancement and disease management program on employee health risk, health conditions, and productivity. Popul Health Manag. 2008; 11(6): 287–96.
- Suhrcke M , McKee M , Stuckler D , Sauto Arce R , Tsolova S , Mortensen J . The contribution of health to the economy in the European Union. Public Health. 2006; 120(11): 994–1001.
- Deogaonkar R , Hutubessy R , van der Putten I , Evers S , Jit M . Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health. 2012; 12: 878.
- Whitney CG , Zhou F , Singleton J , Schuchat A . Benefits from immunization during the vaccines for children program era – United States, 1994–2013. MMWR Morb Mortal Wkly Rep. 2014; 63(16): 352–5. [PubMed Abstract].
- Ehreth J . The global value of vaccination. Vaccine. 2003; 21(7–8): 596–600.
- OECD. Health at a glance 2011: OECD indicators. Available from: http://www.oecd.org/els/health-systems/49105858.pdf [cited 3 July 2015]..
- Barnighausen T , Bloom DE , Canning D , Friedman A , Levine OS , O'Brien J et al. Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine. Vaccine. 2011; 29(13): 2371–80.
- Beutels P . Economic evaluation of vaccination programmes in humans: A methodological exploration with application to hepatitis B, varicella-zoster, measles, pertussis, hepatitis A and pneumococcal vaccination. 2002; Antwerp: University of Antwerp.
- Atkins KE , Shim E , Carroll S , Quilici S , Galvani AP . The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine. 2012; 30(48): 6766–76.
- Vitale F , Barbieri M , Dirodi B , Vitali Rosati G , Franco E . [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at national and regional level in Italy]. Ann Ig. 2013; 25(1): 43–56. [PubMed Abstract].
- Public Health England. Early evidence of the impact of the national rotavirus immunisation programme. Health Prot Rep Wkly Rep. 2014; 8(12): 9–10.
- Public Health England. Invasive meningococcal infections laboratory reports in England and Wales. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/343375/Table_1a_Invasive_meningococcal__E_W_by_capsular_group___epi_year.pdf [cited 28 June 2015]..
- Public Health England. 10 years of meningitis C vaccine: Outstanding health protection measure of the past decade. Available from: http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/NewsCentre/NationalPressReleases/2009PressReleases/09112310yearsofmeningitisCvaccine/ [cited 29 June 2015]..
- Dasbach E , Insinga R , Elbasha E . The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK. BJOG. 2008; 115(8): 947–56.
- Council of the European Union. Council conclusions on vaccinations as an effective tool in public health. 2014; Brussels: Council of the European Union.